Literature DB >> 17458000

Telbivudine.

Jules Dienstag, Chris Easley, Peter Kirkpatrick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17458000     DOI: 10.1038/nrd2295

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  8 in total

1.  Computational model of hepatitis B virus DNA polymerase: molecular dynamics and docking to understand resistant mutations.

Authors:  Pankaj R Daga; Jinsong Duan; Robert J Doerksen
Journal:  Protein Sci       Date:  2010-04       Impact factor: 6.725

2.  Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission.

Authors:  Weihui Sun; Shangfei Zhao; Lei Ma; Anhua Hao; Bo Zhao; Lin Zhou; Fengzhu Li; Mingquan Song
Journal:  BMC Gastroenterol       Date:  2017-04-13       Impact factor: 3.067

3.  Telbivudine treatment of hepatitis B virus-infected pregnant women at different gestational stages for the prevention of mother-to-child transmission: Outcomes of telbivudine treatment during pregnancy.

Authors:  Zhangmin Tan; Yuzhu Yin; Jin Zhou; Lingling Wu; Chengfang Xu; Hongying Hou
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

4.  Developmental consequences of children born from mothers with telbivudine treatment during late pregnancy: A prospective study with 3-year follow-up.

Authors:  Wei Yi; Xiuzhen Cao; Zhan Zeng; Weihua Cao; Ying Zhang; Fangfang Sun; Ying Wang; Gang Wan; Minghui Li; Yao Xie
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

Review 5.  The effects of telbivudine in late pregnancy to prevent intrauterine transmission of the hepatitis B virus: a systematic review and meta-analysis.

Authors:  Min Deng; Xin Zhou; Sheng Gao; Shi-Gui Yang; Bing Wang; Hua-Zhong Chen; Bing Ruan
Journal:  Virol J       Date:  2012-09-04       Impact factor: 4.099

6.  Efficacy and Safety of Telbivudine Compared to Entecavir Among HBeAg+ Chronic Hepatitis B Patients: a Meta-Analysis Study.

Authors:  Jian Liang; Man Jun Jiang; Xin Deng; Xiao Xiao Zhou
Journal:  Hepat Mon       Date:  2013-05-23       Impact factor: 0.660

7.  Effects of telbivudine treatment on the circulating CD4⁺ T-cell subpopulations in chronic hepatitis B patients.

Authors:  Yanhua Zheng; Zemin Huang; Xianhua Chen; Yi Tian; Jun Tang; Yi Zhang; Xiaomin Zhang; Jijun Zhou; Qing Mao; Bing Ni; Qinghong Wang; Yuzhang Wu
Journal:  Mediators Inflamm       Date:  2012-04-11       Impact factor: 4.711

Review 8.  Advances in Therapeutic L-Nucleosides and L-Nucleic Acids with Unusual Handedness.

Authors:  Yuliya Dantsu; Ying Zhang; Wen Zhang
Journal:  Genes (Basel)       Date:  2021-12-24       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.